Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 27 studies | 25% ± 7% | |
capillary endothelial cell | 12 studies | 30% ± 8% | |
endothelial cell of lymphatic vessel | 12 studies | 30% ± 9% | |
non-classical monocyte | 8 studies | 27% ± 9% | |
pericyte | 8 studies | 23% ± 5% | |
endothelial cell of artery | 7 studies | 21% ± 5% | |
endothelial cell of vascular tree | 6 studies | 25% ± 7% | |
plasmacytoid dendritic cell | 6 studies | 25% ± 8% | |
vein endothelial cell | 4 studies | 23% ± 5% | |
glomerular endothelial cell | 3 studies | 28% ± 0% | |
natural killer cell | 3 studies | 18% ± 0% | |
monocyte | 3 studies | 19% ± 3% | |
B cell | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of SH2D3C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3339.33 | 653 / 653 | 100% | 25.09 | 603 / 605 |
breast | 100% | 3437.18 | 459 / 459 | 98% | 12.97 | 1091 / 1118 |
lung | 100% | 7171.99 | 578 / 578 | 95% | 10.67 | 1102 / 1155 |
adrenal gland | 93% | 922.65 | 241 / 258 | 97% | 23.72 | 223 / 230 |
uterus | 100% | 2265.45 | 170 / 170 | 88% | 8.13 | 404 / 459 |
kidney | 99% | 1696.79 | 88 / 89 | 89% | 23.53 | 801 / 901 |
brain | 84% | 1089.83 | 2225 / 2642 | 100% | 12.13 | 703 / 705 |
prostate | 94% | 1216.59 | 231 / 245 | 87% | 6.51 | 439 / 502 |
bladder | 95% | 1498.19 | 20 / 21 | 83% | 6.93 | 419 / 504 |
esophagus | 89% | 1218.03 | 1283 / 1445 | 89% | 7.30 | 162 / 183 |
intestine | 92% | 1208.78 | 889 / 966 | 83% | 7.11 | 435 / 527 |
stomach | 83% | 742.93 | 297 / 359 | 87% | 8.83 | 249 / 286 |
skin | 62% | 628.95 | 1120 / 1809 | 92% | 10.51 | 434 / 472 |
ovary | 59% | 550.12 | 107 / 180 | 80% | 4.95 | 345 / 430 |
pancreas | 26% | 168.84 | 85 / 328 | 96% | 12.30 | 171 / 178 |
liver | 23% | 155.17 | 51 / 226 | 90% | 7.52 | 364 / 406 |
adipose | 100% | 3691.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 47.97 | 29 / 29 |
spleen | 100% | 6518.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.53 | 1 / 1 |
peripheral blood | 99% | 5717.79 | 924 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 2191.27 | 851 / 861 | 0% | 0 | 0 / 0 |
muscle | 89% | 764.81 | 716 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 63% | 813.40 | 844 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 3.58 | 48 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0007254 | Biological process | JNK cascade |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0032587 | Cellular component | ruffle membrane |
GO_0030424 | Cellular component | axon |
GO_0005829 | Cellular component | cytosol |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
Gene name | SH2D3C |
Protein name | SH2 domain containing 3C SH2 domain-containing protein 3C (Cas/HEF1-associated signal transducer) (Chat-H) (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1) (SHEP1) |
Synonyms | NSP3 UNQ272/PRO309/PRO34088 |
Description | FUNCTION: Acts as an adapter protein that mediates cell signaling pathways involved in cellular functions such as cell adhesion and migration, tissue organization, and the regulation of the immune response . Plays a role in integrin-mediated cell adhesion through BCAR1-CRK-RAPGEF1 signaling and activation of the small GTPase RAP1 . Promotes cell migration and invasion through the extracellular matrix . Required for marginal zone B-cell development and thymus-independent type 2 immune responses (By similarity). Mediates migration and adhesion of B cells in the splenic marginal zone via promoting hyperphosphorylation of NEDD9/CASL (By similarity). Plays a role in CXCL13-induced chemotaxis of B-cells (By similarity). Plays a role in the migration of olfactory sensory neurons (OSNs) into the forebrain and the innervation of the olfactory bulb by the OSN axons during development (By similarity). Required for the efficient tyrosine phosphorylation of BCAR1 in OSN axons (By similarity). .; FUNCTION: [Isoform 1]: Important regulator of chemokine-induced, integrin-mediated T lymphocyte adhesion and migration, acting upstream of RAP1 (By similarity). Required for tissue-specific adhesion of T lymphocytes to peripheral tissues (By similarity). Required for basal and CXCL2 stimulated serine-threonine phosphorylation of NEDD9 (By similarity). May be involved in the regulation of T-cell receptor-mediated IL2 production through the activation of the JNK pathway in T-cells (By similarity). .; FUNCTION: [Isoform 2]: May be involved in the BCAR1/CAS-mediated JNK activation pathway. . |
Accessions | ENST00000373276.7 [Q8N5H7-4] ENST00000429553.5 [Q8N5H7-3] ENST00000629203.2 [Q8N5H7-6] ENST00000314830.13 [Q8N5H7-1] ENST00000414380.1 ENST00000373277.8 [Q8N5H7-2] Q5JU32 ENST00000440630.5 ENST00000420366.5 [Q8N5H7-5] Q8N5H7 H0Y5X5 |